These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37520615)

  • 1. Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season.
    Gherasim A; Dietsch F; Beck M; Domis N; de Blay F
    World Allergy Organ J; 2023 Jul; 16(7):100801. PubMed ID: 37520615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU).
    Ellis AK; Soliman M; Steacy LM; Adams DE; Hobsbawn B; Walker TJ
    Allergy Asthma Clin Immunol; 2016; 12():53. PubMed ID: 27777594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber.
    Gherasim A; Fauquert JL; Domis N; Siomboing X; de Blay F
    Clin Transl Allergy; 2021 Aug; 11(6):e12053. PubMed ID: 34429874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental exposure unit simulates natural seasonal birch pollen exposures while maximizing change in allergic symptoms.
    Ellis AK; DeVeaux M; Steacy L; Ramesh D; Suprun M; Langdon S; Wang CQ; Adams D; Thiele J; Walker T; Perlee LT; O'Brien MP
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):488-495.e5. PubMed ID: 34186172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients.
    Bergmann KC; Krause L; Hiller J; Becker S; Kugler S; Tapparo M; Pfaar O; Zuberbier T; Kramer MF; Guethoff S; Graessel A
    World Allergy Organ J; 2021 Jan; 14(1):100494. PubMed ID: 33376575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Seasonal Priming on Specific Inhalation Challenges With Birch and Grass Allergen Among Persons With Allergic Rhinitis.
    Ørby PV; Bønløkke JH; Bibby BM; Ravn P; Hertel O; Sigsgaard T; Schlünssen V
    Front Allergy; 2021; 2():737799. PubMed ID: 35387055
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of silver birch and house dust mite extracts derived from licensed sublingual tablets for nasal allergen challenge.
    Olivieri B; Gil AJ; Stoenchev K; Durham SR; Scadding G
    Clin Transl Allergy; 2024 May; 14(5):e12360. PubMed ID: 38779783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
    Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
    Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for a homogeneous distribution of pollens in an environmental exposure chamber.
    Kenney P; Bønløkke J; Hilberg O; Ravn P; Schlünssen V; Sigsgaard T
    Clin Exp Allergy; 2016 Sep; 46(9):1176-84. PubMed ID: 27144495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and seasonal exposure to birch pollen in allergic rhinitis and allergic asthma with regard to the inflammatory response.
    Kämpe M; Janson C; Stålenheim G; Stolt I; Carlson M
    Clin Respir J; 2010 Jan; 4(1):37-44. PubMed ID: 20298416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis.
    Kopp MV; Brauburger J; Riedinger F; Beischer D; Ihorst G; Kamin W; Zielen S; Bez ; Friedrichs F; Von Berg A; Gerhold K; Hamelmann E; Hultsch ; Kuehr J
    J Allergy Clin Immunol; 2002 Nov; 110(5):728-35. PubMed ID: 12417881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-reactive antibodies are found in nasal fluids from patients with birch pollen-induced intermittent allergic rhinitis, but not in healthy controls.
    Benson M; Reinholdt J; Cardell LO
    Allergy; 2003 May; 58(5):386-92. PubMed ID: 12752324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical symptoms and biomarkers of Bermuda grass-induced allergic rhinitis using the nasal allergen challenge model.
    Rawls M; Thiele J; Adams DE; Steacy LM; Ellis AK
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):608-615.e2. PubMed ID: 32173484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
    Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
    J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
    Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C
    J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas-An EAACI Task Force Report.
    Pfaar O; Karatzas K; Bastl K; Berger U; Buters J; Darsow U; Demoly P; Durham SR; Galán C; Gehrig R; Gerth van Wijk R; Jacobsen L; Katsifarakis N; Klimek L; Saarto A; Sofiev M; Thibaudon M; Werchan B; Bergmann KC
    Allergy; 2020 May; 75(5):1099-1106. PubMed ID: 31721236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.
    Ellis AK; Soliman M; Steacy L; Boulay MÈ; Boulet LP; Keith PK; Vliagoftis H; Waserman S; Neighbour H
    Allergy Asthma Clin Immunol; 2015; 11(1):16. PubMed ID: 25945101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.